Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Direct Digital DRCT Mar 6, 2026 1.00 -4.23   
 DocuSign DOCU Mar 6, 2026 48.69 +0.95   
 Douyu International ADR DOYU Mar 6, 2026 4.96 -1.98   
 Dropbox A DBX Mar 6, 2026 26.79 +1.55   
 DXC Technology DXC Mar 6, 2026 12.95 -1.82   
 EPAM Systems EPAM Mar 6, 2026 145.87 +0.89   
 ePlus PLUS Mar 6, 2026 78.00 -3.02   
 Equinix EQIX Mar 6, 2026 937.20 -1.66   
 Everbright Digital Holding EDHL Mar 6, 2026 3.25 +19.49   
 Evolv Technologies A EVLV Mar 6, 2026 5.08 -2.12   
 ExlService EXLS Mar 6, 2026 32.51 -0.12   
 Fair Isaac FICO Mar 6, 2026 1 476.00 +0.06   
 Fidelity National Information Services FIS Mar 6, 2026 51.49 +1.80   
 Firefly Neuroscience AIFF Mar 6, 2026 1.85 +30.28   
 Fiverr FVRR Mar 6, 2026 11.33 -0.44   
 Fluent FLNT Mar 6, 2026 3.63 +12.38   
 Formula Systems (1985) ADR FORTY Mar 6, 2026 128.20 0.00   
 Fortinet FTNT Mar 6, 2026 83.67 -0.89   
 Gartner IT Mar 6, 2026 169.00 -1.16   
 GD Culture Group GDC Mar 6, 2026 3.83 -0.78   
 GDS ADR GDS Mar 6, 2026 40.87 +7.24   
 Gen Digital GEN Mar 6, 2026 22.61 0.00   
 Global Engine Group Holding GLE Mar 6, 2026 0.38 -5.09   
 Global Mofy AI GMM Mar 6, 2026 1.11 -3.48   
 Globant GLOB Mar 6, 2026 51.61 -2.99   
 GoodRx A GDRX Mar 6, 2026 2.28 -0.44   
 Gorilla Technology Group GRRR Mar 6, 2026 12.56 +2.28   
 Grid Dynamics A GDYN Mar 6, 2026 6.65 -7.06   
 Haoxi Health Technology HAO Mar 6, 2026 1.20 +9.09   
 Helport AI Limited - Ordinary Shares HPAI Mar 6, 2026 2.86 +0.39   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.